OncoNano Medicine
Bhargavi Allu is a seasoned analytical chemist with extensive experience in pharmaceutical development and quality assurance. Currently serving as a Sr. Analytical Chemist at OncoNano Medicine, Inc. since July 2022, Bhargavi previously held the position of CW-Senior Associate Scientist in process development at Amgen, contributing to analytical method development and compliance with cGMP standards. Earlier roles included Senior Executive in Analytical R&D at Micro Labs Ltd., where Bhargavi led method development and validation for key pharmaceutical products, and Senior Research Associate at Hetero Drugs Ltd., focusing on analytical method validation for small molecules. Bhargavi's academic background includes a Master's degree in Organic Chemistry from Andhra University and a Bachelor's degree in Biochemistry, Biotechnology, and Chemistry from Kakatiya University.
This person is not in any teams
OncoNano Medicine
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.